Article

Redesigned upstream processing enables a 24-hour workflow from <i>E. coli</i> cells to cell-free protein synthesis

2019-08-13

Abstract excerpt

Cell-free protein synthesis (CFPS) platforms have undergone numerous workflow improvements to enable diverse applications in research, biomanufacturing, point-of-care detection, therapeutics, and education using affordable laboratory equipment and reagents. The Escherichia coli cell extract-based platform, being one of the most affordable and versatile CFPS platforms, has been broadly adopted. In spite of the pro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f017f286-912d-5dcf-b4ea-425b58da17c0
DOI: 10.1101/729699

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Redesigned upstream processing enables a 24-hour workflow from <i>E. coli</i> cells to cell-free protein synthesisDOI 10.1101/729699Read

Tuning Cell-free Composition Controls the Time-delay, Dynamics, and Productivity of TX-TL ExpressionSemantic proximity Read

An Automated End-to-End Workflow for Production of Secreted Proteins in Transfected Mammalian CellsSemantic proximity Read

Cell-Free Protein Synthesis with Technical Additives – Expanding the Parameter Space of <i>In Vitro</i> Gene ExpressionSemantic proximity Read

A scalable cell-free manufacturing platform for two-step bioproduction of immunogenic conjugate vaccinesSemantic proximity Read

Cell-free protein synthesis from genomically recoded bacteria enables multisite incorporation of noncanonical amino acids.Semantic proximity Read

Construction of Probiotic Escherichia coli Nissle 1917 as a Next- Generation Expression Platform and Its Application in Therapeutic Protein ProductionSemantic proximity Read

Efficient cell-free translation from diverse human cell typesSemantic proximity Read

High-throughput recombinant protein expression in <i>Escherichia coli</i> : current status and future perspectivesSemantic proximity Read

Scalable Production of a <i>De Novo</i> SARS-CoV-2 Antiviral miniprotein in E <i>scherichia coli</i>Semantic proximity Read

Closing the Loop: Autonomous High-Throughput Strain Characterisation from Frozen Cell Bank to Product AssaySemantic proximity Read

Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor binding domain in engineered <i>Komagataella phaffii</i>Semantic proximity Read

Techno-Economic Assessment of Cell-Free Synthesis of Monoclonal Antibodies Using CHO Cell ExtractsSemantic proximity Read